Answers are grounded in this paper and cite their sources.
Biotransformation of volatile anesthetics is of considerable interest because of known associations between metabolism of certain anesthetics and specific organ toxicities. For example, renal insufficiency after methoxyflurane anesthesia is intimately linked to the metabolism of this anesthetic [1]. One of the products of methoxyflurane metabolism, inorganic fluoride ion, has been implicated in the mechanism of methoxyflurane nephrotoxicity [2]. The fulminant hepatitis that occurs rarely after halothane anesthesia is related to the product of oxidative hepatic halothane metabolism, trifluoroacyl chloride, which binds to liver proteins forming trifluoroacetylated proteins, or neoantigens. In susceptible individuals, these neoantigens stimulate formation of antibodies that mediate hepatic destruction upon subsequent halothane exposure [3]. Biotransformation of every volatile anesthetic agent synthesized and/or introduced into clinical trials since methoxyflurane and halothane has been intensely scrutinized. Metabolism of sevoflurane, in vitro and in vivo, has been investigated in several animal species and in humans. Advances in enzyme biochemistry and molecular biology have illuminated similarities and differences between animal and human drug metabolizing enzymes, permitting both appropriate extrapolation of animal data to humans and reconciliation of discrepancies between animal and human sevoflurane studies. The relationship between sevoflurane metabolism and potential toxicity has been monitored extensively. There are now considerable data regarding sevoflurane metabolism and the absence to date of metabolism-based hepatic and renal toxicities in animals and humans. Indeed, studies of sevoflurane biotransformation may result in revision of some classically held concepts regarding volatile anesthetic metabolism and toxicity. General Like all fluorinated volatile anesthetics, sevoflurane undergoes biotransformation to organic and inorganic fluoride metabolites Figure 1. Cytochrome P-450-catalyzed sevoflurane oxidation at the fluoromethoxy carbon produces a transient intermediate that decomposes to inorganic fluoride and the organic fluoride metabolite hexafluoroisopropanol (HFIP) [4,5]. HFIP is the only organic fluoride metabolite of sevoflurane identified to date. Fluoride and HFIP are formed in equimolar amounts [6]. Substitution of deuterium for hydrogen on the fluoromethoxy carbon of sevoflurane markedly retards metabolism to fluoride and HFIP in vitro and in vivo, further suggesting that sevoflurane metabolism occurs almost exclusively on the fluoromethoxy carbon [6,7].Figure 1: Metabolism of sevoflurane. Major metabolites are inorganic fluoride and hexafluoroisopropanol (HFIP), which is subsequently glucuronidated.There is no evidence that HFIP undergoes further defluorination or oxidative (Phase I) metabolism. HFIP does undergo conjugation (Phase II metabolism) with glucuronic acid, forming HFIP-glucuronide, which is excreted in urine [4,5]. There is no evidence for HFIP toxicity at concentrations produced clinically, and HFIP is nonmutagenic in the Ames test (data on file at Abbott Laboratories, Abbott Park, IL). The chemical structure of sevoflurane, unlike that of other volatile anesthetics, dictates that it cannot undergo metabolism to an acyl halide. Sevoflurane metabolism does not result in the formation of trifluoroacetylated liver proteins [8] and therefore cannot stimulate the formation of antitrifluoroacetylated protein antibodies. The absence of sevoflurane modification of liver proteins by covalent binding has been demonstrated [8]. In this regard, sevoflurane differs from halothane, enflurane, and isoflurane, all of which are metabolized to reactive acyl halide intermediates. Desflurane may theoretically undergo metabolism to an acyl halide, based on its structure [9], although this has not been observed [8]. For anesthetics such as enflurane and isoflurane, acyl halides can bind to liver proteins, producing neoantigens that cross-react with antihalothane antibodies, provoking clinical cross-sensitization between these anesthetics [10]. Sevoflurane, because of its unique metabolism, would not be expected to produce such a reaction. Similarly, no other reactive intermediates resulting from sevoflurane biotransformation have been postulated or identified. The primary sevoflurane metabolites, fluoride and HFIP, are stable and do not appear to be reactive. Animal Investigations Inorganic fluoride is a metabolite common to the biotransformation of sevoflurane, as well as methoxyflurane, halothane, enflurane, isoflurane, and desflurane. Given the ubiquitous nature of this metabolite, coupled with the ease in measurement (using a fluoride-selective electrode), fluoride formation has been used as the most common index of volatile anesthetic biotransformation. In Vitro Studies Most in vitro animal investigations have compared rat hepatic microsomal metabolism of sevoflurane with that of other anesthetics and examined the effect of enzyme inducers or inhibitors. Initial experiments suggested that sevoflurane and methoxyflurane were metabolized at essentially similar rates by rat liver microsomes in vitro [11]. This equivalence has not been substantiated in subsequent investigations. Rates of sevoflurane metabolism were found to be approximately half those of methoxyflurane, similar to those of enflurane metabolism, and approximately 50% greater than those of isoflurane metabolism in several investigations with rat liver microsomes [12-14]. For example, rat liver microsomal defluorination rates for methoxyflurane, sevoflurane, enflurane, and isoflurane were (mean +/- SE) 0.31 +/- 0.02, 0.13 +/- 0.01, 0.15 +/- 0.07, and 0.08 +/- 0.01 nmol centered dot min-1 centered dot nmol P-450-1[13]. In guinea pig liver slices incubated for 6 h, rates of inorganic fluoride formation from sevoflurane, isoflurane, and desflurane were (mean +/- SE) 720 +/- 115, 190 +/- 15, and 27 +/- 5 pmol/mg slice weight [15,16]. In most in vitro studies, the comparative rates of rodent liver microsomal metabolism were methoxyflurane > sevoflurane >or=to enflurane > isoflurane > desflurane. Drug-induced increases in hepatic drug metabolizing activity (enzyme induction) may alter the rate of sevoflurane metabolism. Enzyme induction by isoniazid treatment produced a substantial and consistent four- to fivefold increase in sevoflurane defluorination by rat liver microsomes in vitro [6,13,17]. The degree of isoniazid induction of rat liver microsomal sevoflurane metabolism was comparable to that seen with methoxyflurane, enflurane, and isoflurane [13,17]. Chronic ethanol treatment of rats caused a threefold increase in sevoflurane defluorination by rat liver microsomes in vitro [18]. The effects of acute ethanol administration on rat sevoflurane metabolism have not been studied. Acute ethanol administration, however, has been shown to inhibit enflurane metabolism in rats in vivo [19], and similar effects on sevoflurane defluorination would be expected since these two anesthetics are metabolized by the same ethanolinhibitable enzyme. In both rats and rabbits, isoniazid and ethanol induce the cytochrome P-450 isoform known as P-450 2E1 [20]. P-450 2E1 has been shown to be the major enzyme in rat [21] and rabbit [22] liver microsomes that metabolizes sevoflurane. P-450 2E1 has also been purified from rabbit liver and shown to catalyze this activity [22]. Untreated diabetes in rats has been shown to enhance the in vitro and in vivo defluorination of enflurane and isoflurane [23], which are metabolized predominantly by P-450 2E1. Insulin treatment prevented the stimulation of metabolism. Since untreated diabetes increases P-450 2E1 activity and this enzyme is the major P-450 isoform responsible for sevoflurane metabolism in rats, it is likely that sevoflurane defluorination in vitro and in vivo would also be enhanced in untreated diabetic rats. Similarly, obesity induces P-450 2E1 activity in rats, increases enflurane metabolism in vitro [24], and would be expected to stimulate microsomal sevoflurane metabolism. In contrast to isoniazid, enzyme induction by phenobarbital or phenytoin pretreatment produced small (two- to threefold) or no increases in sevoflurane metabolism by rat [6,12,14] or rabbit [22] liver microsomes in vitro. Barbiturates and phenytoin induce P-450 cytochrome families P-450 2B, P-450 2C, and P-450 3A. By comparison, methoxyflurane metabolism was increased substantially more, 10- to 13-fold, by similar phenobarbital or phenytoin pretreatment [12,14,22]. Such marked induction of defluorination by barbiturates is unique to methoxyflurane; metabolism of no other fluorinated agent, including sevoflurane, is so induced by barbiturates [17]. In contrast to the mild stimulation of sevoflurane metabolism caused by barbiturate induction, enzyme induction by 3-methylcholanthrene or beta-naphthoflavone (polycyclic aromatic hydrocarbons that induce P-450 1A enzymes) did not increase sevoflurane metabolism in rats in vitro [12,13]. In Vivo Studies Metabolism of sevoflurane in animals in vivo has been studied most extensively in rats. After 4 h of 1.4% sevoflurane, mean peak serum fluoride concentrations were about 12 micro Meter compared with approximately 76 micro Meter after 3 h of 0.5% methoxyflurane [11]. Serum fluoride concentrations returned to preanesthesia values more quickly after sevoflurane anesthesia, decreasing to baseline the day after anesthesia. In contrast, serum fluoride concentrations remained increased for more than 4 days after methoxyflurane anesthesia [11]. Urinary inorganic fluoride excretion after sevoflurane was estimated at one third to one fourth that after methoxyflurane. The time course of sevoflurane serum fluoride concentrations resembled that after anesthesia with enflurane [11]. Serum fluoride concentrations in rats after anesthesia with several anesthetics are shown in Figure 2.Figure 2: Comparison of serum fluoride (F-) concentrations after anesthesia in Fischer 344 rats. Reproduced from Cook et al. [11] with permission.It is important to distinguish between the rate of anesthetic metabolism and the extent of metabolism. Peak serum or plasma fluoride concentrations are more closely related to the rate of biotransformation. The extent of metabolism (frequently measured as the area under the serum fluoride concentration-time curve or total urinary fluoride excretion) is dependent on both the rate of metabolism and the residence time of the agent in the body. Highly fat-soluble anesthetics, such as methoxyflurane, are eliminated slowly and are therefore available for metabolism for several days. In contrast, less-soluble anesthetics such as sevoflurane are eliminated rapidly, limiting availability for biotransformation. The extent of anesthetic biotransformation in rats, estimated from total urinary fluoride excretion, is illustrated in Figure 3.Figure 3: Comparison of the extent of anesthetic defluorination in Fischer 344 rats. Daily urinary inorganic fluoride excretion (mean +/- SE) after 1 h of anesthetic exposure is shown. Data for methoxyflurane (0.5%) and sevoflurane (1.4%) are redrawn from Cook et al. [11] with permission. Data for enflurane (2.5%) are redrawn from Barr et al. [25] with permission. Data for isoflurane (2% for 4 h) are normalized to a 1-h exposure and redrawn from Hitt et al. [26] with permission.Enzyme induction does alter the rate and extent of sevoflurane metabolism in animals in vivo. Similar to results obtained in vitro, isoniazid has been shown to significantly induce the metabolism of sevoflurane in rats in vivo [6,27]. Peak plasma fluoride concentrations after sevoflurane were twofold higher in isoniazidtreated rats compared with controls Figure 4. These investigators also found that enzyme induction by chronic ethanol treatment increased sevoflurane metabolism in rats in vivo [27]. The effects of obesity on rat sevoflurane metabolism in vivo are not known. However, obese rats, with higher hepatic P-450 2E1 contents, showed two- to threefold higher rates of enflurane and isoflurane metabolism in vivo compared with rats fed a normal diet [24,28]. Sevoflurane metabolism would therefore be expected to be similarly increased in obese rats.Figure 4: Influence of enzyme induction on sevoflurane metabolism in rats. Peak serum fluoride concentrations (mean +/- SE, n = 6) were measured after anesthetic of sevoflurane. from the data of et al. with contrast to induction of P-450 2E1 enzyme induction by phenobarbital in only a small increase in urinary fluoride excretion after sevoflurane anesthesia, with no effect on serum fluoride In plasma fluoride concentrations after of sevoflurane were twofold greater in rats compared with untreated animals [6]. This result is to however, because baseline fluoride concentrations were in and and the increase in plasma fluoride compared with plasma fluoride concentrations was similar in both [6]. et al. found more substantial induction of sevoflurane defluorination by with threefold greater peak serum fluoride concentrations after anesthetic of sevoflurane in animals compared with untreated controls Figure 4. induction of sevoflurane defluorination was markedly than that of methoxyflurane, which was increased at threefold and also for several days no effect on rat isoflurane defluorination in vivo investigations of sevoflurane biotransformation have been in species other than rats. In with sevoflurane for 3 h, an fluoride of +/- micro Meter was at the of anesthesia, which to +/- micro Meter at h and to after h Urinary excretion in was anesthetic exposure and essentially after was estimated that than of the sevoflurane was metabolized in this One in examined the relationship between sevoflurane and biotransformation were to and sevoflurane for h with peak serum fluoride concentrations were +/- +/- +/- and +/- micro Meter with and sevoflurane, and were after of urine fluoride excretion was +/- +/- +/- and +/- micro in the and There was a relationship between the rate of fluoride formation serum fluoride and sevoflurane and also between urine fluoride excretion and sevoflurane In one drug as an index of metabolism, et al. found metabolism of sevoflurane than of desflurane. This result was in with other animal and human studies, for that were to the Investigations In Vitro Studies Metabolism of sevoflurane and other volatile anesthetics has been examined in vitro microsomes from human The of hepatic microsomal fluoride at anesthetic concentrations was methoxyflurane > sevoflurane > enflurane > isoflurane > desflurane > Figure In a of 12 human the mean rate of defluorination of sevoflurane was one third that of methoxyflurane, and approximately that of enflurane liver microsomal volatile anesthetic The Figure defluorination (mean +/- of of methoxyflurane sevoflurane enflurane isoflurane and desflurane by a human liver The the metabolism (mean +/- SE) of methoxyflurane, sevoflurane, and enflurane in 12 human Reproduced from et al. with major human liver enzyme responsible for sevoflurane metabolism in vitro has been identified as cytochrome P-450 2E1 one of approximately human hepatic P-450 identified to date. In a of human sevoflurane metabolism was with P-450 2E1 protein and P-450 2E1 activity Figure 6 and by for P-450 2E1. Sevoflurane was similar to enflurane, in that both were metabolized predominantly by this isoform In contrast, methoxyflurane is metabolized by several human P-450 in to the enzyme P-450 2E1 These and P-450 of these are induced by phenobarbital and/or including and P-450 of sevoflurane defluorination with microsomal cytochrome P-450 2E1 and activity P-450 2E1 was by P-450 2E1 activity was measured by data the mean of from one human Reproduced from et al. with liver microsomes have also been used to the of HFIP, a primary sevoflurane metabolite, to further biotransformation. The defluorination of sevoflurane was compared with that of HFIP under Figure defluorination of HFIP was These results that HFIP is to further oxidative that HFIP excretion HFIP and that clinical fluoride is exclusively to the defluorination of liver microsomal metabolism of sevoflurane and hexafluoroisopropanol for 1 microsomal and 1 micro sevoflurane or micro HFIP in Fluoride concentrations were measured with a Fluoride formation from HFIP was the of nmol centered dot centered dot Sevoflurane data are from the metabolism of sevoflurane in human and compared it with renal metabolism of methoxyflurane microsomes did catalyze volatile anesthetic at rates to than those observed with human liver In the human defluorination of sevoflurane was rates of methoxyflurane defluorination were substantially greater and Figure did not catalyze anesthetic 2E1 and/or and P-450 were implicated in renal microsomal anesthetic These defluorination of methoxyflurane 3 to than that of sevoflurane. of human renal methoxyflurane metabolism the of methoxyflurane metabolism in humans human microsomal methoxyflurane and sevoflurane defluorination (mean +/- SE, n = microsomal protein and were incubated for was from a and other organ were identified as known to alter Reproduced from et al. with Vivo Studies and the metabolism of sevoflurane in in sevoflurane for 1 was estimated that of the sevoflurane was metabolized to fluoride and Peak serum fluoride concentrations at the of were increased +/- micro Meter and to +/- micro Meter on the day after Major metabolites in urine were inorganic fluoride and an organic identified as the of HFIP, with no volatile metabolites excreted in HFIP for of the organic metabolites There was a between urinary excretion of HFIP and organic fluoride of further suggesting that HFIP was the major urinary organic fluoride of may have for the than of organic as HFIP, which was also observed more investigations have subsequently the metabolism of sevoflurane to inorganic fluoride The time course of plasma fluoride concentrations from a is shown in Figure or serum inorganic fluoride concentrations in normal and after are in the of micro Meter after are micro Meter and after greater sevoflurane are micro Meter SE) plasma inorganic fluoride (F-) concentrations and after sevoflurane anesthesia +/- anesthetic in and II Reproduced from et al. with metabolism of sevoflurane to HFIP has been studied more HFIP and were in 5 after the of sevoflurane anesthesia Figure The of HFIP in as the with HFIP concentrations than of total HFIP of HFIP into was In an of sevoflurane, peak plasma HFIP concentrations h after the of sevoflurane anesthesia, with an time to of h Figure After of anesthesia, plasma HFIP concentrations were approximately 50% greater than fluoride concentrations Figure The peak and plasma concentrations of compared with HFIP, likely fluoride into compared with of HFIP by renal of hexafluoroisopropanol (HFIP) and total and HFIP in (mean +/- SE) in with sevoflurane. Reproduced from et al. with concentrations (mean +/- SE) of hexafluoroisopropanol (HFIP) and fluoride plasma fluoride fluoride in with sevoflurane for 3 h, the 3 Reproduced from et al. with is no evidence to date that HFIP is in humans. The of HFIP formed after sevoflurane anesthesia was This is well the for HFIP toxicity in rats = (data on file at Abbott In the of HFIP since are more excreted and than Sevoflurane defluorination has been compared with defluorination of other volatile The of peak plasma fluoride concentrations in humans is methoxyflurane > sevoflurane > enflurane > isoflurane > desflurane Figure Peak fluoride concentrations after sevoflurane are approximately higher than those after however, fluoride concentrations after sevoflurane significantly than those after enflurane and markedly than those after methoxyflurane. methoxyflurane, in which fluoride concentrations micro Meter and are for several fluoride concentrations after sevoflurane may peak micro Meter the course of several In the plasma fluoride concentration-time for sevoflurane most closely that of Serum inorganic fluoride concentrations (mean +/- SE) and after methoxyflurane, enflurane, sevoflurane, isoflurane, and desflurane anesthesia h from the data of et al. and et al. with metabolism in has been by et of from to 1 sevoflurane. inorganic fluoride concentrations micro Meter after of sevoflurane. There was a between peak plasma fluoride and the of sevoflurane, and was no relationship between and peak plasma fluoride fluoride concentrations after 1 sevoflurane were than those after methoxyflurane in greater than those after similar exposure to enflurane in Most of the investigations have on peak plasma fluoride concentrations and after anesthesia. These rates of hepatic metabolism a be between the rate of metabolism and the total extent of metabolism. The extent of metabolism of sevoflurane, that of other volatile anesthetics, has been estimated by both the and by of urinary The metabolism as the between anesthetic and that from is to certain and of urinary fluoride may also the extent of metabolism because of fluoride in or metabolite The extent of sevoflurane metabolism has been both and urinary metabolite are in 1. on urinary fluoride excretion, and sevoflurane metabolism as of the estimated and also urine fluoride excretion, sevoflurane metabolism as +/- of the of investigators that 50% of fluoride into the was in and this et al. found that +/- of sevoflurane was eliminated in the urine as the more nature of fluoride urinary fluoride was to that of sevoflurane metabolism to HFIP is to undergo substantially than urinary HFIP excretion may a more of sevoflurane metabolism. urinary HFIP excretion, the extent of sevoflurane metabolism was as +/- of the In contrast to all these et al. did not metabolism of sevoflurane by or by This however, has not been substantiated in other 1: of Metabolism of of extent of anesthetic metabolism is methoxyflurane > halothane > enflurane > sevoflurane > isoflurane > desflurane. The extent of sevoflurane metabolism, is than that of enflurane halothane and methoxyflurane the that both sevoflurane and methoxyflurane may result in plasma fluoride concentrations micro the extent of sevoflurane metabolism is substantially than that of methoxyflurane metabolism. the rate of defluorination and peak plasma fluoride concentrations of sevoflurane are those of enflurane, the total extent of sevoflurane metabolism is approximately half that of enflurane metabolism, the most all investigations The extent of sevoflurane metabolism was estimated as to or that of enflurane metabolism although the for of anesthetic metabolism in these studies are substantially from those in The human cytochrome P-450 isoform predominantly responsible for clinical sevoflurane metabolism has been identified as P-450 2E1 In with an of P-450 2E1 to sevoflurane anesthesia, urinary excretion of fluoride and HFIP were by and compared with untreated metabolism of sevoflurane was similar to that of enflurane, which is also metabolized predominantly by P-450 2E1 or drug sevoflurane metabolism can be identified from clinical or by extrapolation from certain appropriate animal or in vitro human investigations These are based on that alter the activity of P-450 2E1. of P-450 2E1 activity by sevoflurane metabolism The of obesity on sevoflurane metabolism has been investigated in two studies with et al. found that in obese compared with serum inorganic fluoride concentrations increased more rapidly, peak fluoride concentrations were area under the fluoride time curve was and urinary fluoride excretion was In contrast, et al. found no in plasma inorganic fluoride concentrations in obese One in these two which was to the effect of was the potential of liver in the two Most of the in the by et al. liver which has been shown to result in higher hepatic P-450 2E1 and greater rates of anesthetic metabolism of on results of human liver experiments in vitro, it was that barbiturates would have no effect on human sevoflurane metabolism in vivo This subsequently was in a clinical normal in which induction of by phenobarbital pretreatment did not significantly alter the total extent of sevoflurane metabolism, measured as the area under the curve that barbiturate effects on sevoflurane metabolism in humans markedly from those in animals most likely because P-450 2B, the major P-450 isoform in rats, is at in humans 2: Sevoflurane Metabolism in to and similarities between human and animal P-450 is a between animals and humans with to the effects of P-450 2E1 inducers and and animals appear to be an for P-450 sevoflurane metabolism. on animal of anesthetic metabolism, and drug likely to human sevoflurane metabolism are also in of P-450 2E1 by chronic isoniazid treatment increases the metabolism of enflurane and would similarly be expected to increase the metabolism of sevoflurane, since both are metabolized by P-450 2E1. chronic ethanol and untreated diabetes induce P-450 2E1 in animals and therefore be expected to increase human sevoflurane metabolism. Sevoflurane Metabolism and Metabolism of sevoflurane resulting in inorganic fluoride concentrations micro Meter has been of investigations with methoxyflurane demonstrated that the and of renal was with peak serum inorganic fluoride with toxicity observed at peak serum fluoride concentrations of micro mild clinical toxicity observed at peak serum fluoride concentrations of micro and nephrotoxicity with peak serum fluoride concentrations of micro Meter [1]. The potential of inorganic fluoride in the of renal insufficiency has been to all fluorinated anesthetics, and the classically regarding anesthetic nephrotoxicity is that the for renal toxicity is a plasma fluoride of micro Meter [2]. In several of the investigations in those with sevoflurane peak inorganic fluoride concentrations micro for of renal or measured by serum and or urine by to or by increase in excretion was observed in these 3: Serum or Fluoride After Sevoflurane both sevoflurane and methoxyflurane metabolism may result in plasma concentrations micro are differences in the metabolism of these 4. These differences may the in the renal effects of sevoflurane and methoxyflurane 4: Comparison of Sevoflurane and Metabolism and Metabolism of sevoflurane to reactive intermediates and has also been of halothane, enflurane, and isoflurane, sevoflurane does not undergo metabolism to reactive acyl halide intermediates and does not bind to liver HFIP does not appear to be a reactive metabolite, and no other organic sevoflurane metabolites have been identified. of hepatic after sevoflurane anesthesia have been however, relationship to sevoflurane biotransformation is of sevoflurane biotransformation are from the investigations. Metabolism is with fluoride and HFIP in plasma after the of sevoflurane administration Peak plasma fluoride concentrations approximately 1 h after the of sevoflurane administration in most of the or of exposure from Peak plasma inorganic fluoride concentrations are to sevoflurane measured in Inorganic fluoride concentrations after of sevoflurane administration, with concentrations well peak by the HFIP is with more than in plasma as the HFIP concentrations peak than fluoride both metabolites are eliminated at similar rates Metabolism of sevoflurane does not to the of clinical drug effect unlike more extensively metabolized such as halothane Sevoflurane is metabolized by P-450 so and drug P-450 2E1 activity also sevoflurane metabolism The extent of metabolism of sevoflurane, to is than that of all other volatile anesthetics isoflurane and desflurane. has been that the anesthetic biotransformation because anesthetic toxicity is related to anesthetic metabolism to date that biotransformation of sevoflurane has not been related to hepatic or renal toxicity. Sevoflurane does not result in formation of liver neoantigens or other reactive both sevoflurane and methoxyflurane may produce plasma fluoride concentrations in of micro have not produced the same anesthetic metabolism and anesthetic toxicity can no be The of sevoflurane into clinical stimulate investigations into of anesthetic toxicity and clinical investigations regarding the relationship between anesthetic metabolism and organ toxicity.
No takes yet. Share an insight, caveat, or question.
Evan D. Kharasch (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: